Return to homepagePandemic Pact

Covid-19: SARS-CoV-2 genomic surveillance

  • Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
  • Total publications:0 publications

Grant number: 142006594

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2024

  • Known Financial Commitments (USD)

    $1,641,343.5

  • Funder

    State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)

  • Principal Investigator

    Schneider Katrin

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The aim of this contract is to ensure national genomic surveillance of the SARS-CoV-2 virus. This virus can change continuously through mutations, meaning that several variants can be circulating. The focus of genomic surveillance will be on virus variants that cause severe disease and lead to hospitalization, as well as virus variants that could impact clinical care or the effectiveness of vaccination, as well as samples from the Sentinella reporting system. In addition (outside of this contract), sequencing of wastewater samples (wastewater monitoring) will be carried out to monitor circulating virus variants in the population. The subsidy from this contract enables the continuation of the national genomic surveillance program for the SARS-CoV-2 virus. The surveillance program includes a network of laboratories ...